In Intermed II we study stock awards, options and various incentives. We reported yesterday that some Goldman execs may be arming themselves. Now comes the story that the back lash over bonuses is so great that Goldman is considering awarding stock rather than cash. No word on when that stock could be sold.

This backlash is coming at Dow 10,500, let it sink a few thousand points again and by next fall, public ire will really be on boil.

Posted in

Leave a comment